Sonendo, Inc. (SONX) Research
Sonendo, Inc. operates as a commercial-stage medical technology firm, dedicated to innovating, producing, and marketing advanced devices for root canal treatment across the United States and Canada. A flagship offering is GentleWave, an innovative device for addressing tooth decay that meticulously cleans and sanitizes the intricate microscopic passages within teeth without the need for removing any natural tooth structure. The company's product line also features SoundSeal, a specialized material used to construct and seal dental crowns, alongside its proprietary Sonendo-branded liquid solution of EDTA, which assists in the debridement and disinfection processes crucial for root canal systems. Furthermore, Sonendo provides "The Digital Office," a comprehensive practice management software solution designed to foster an integrated digital environment for dental professionals. Established in 2006, the organization was initially known as Dentatek Corporation before officially rebranding to Sonendo, Inc. in March 2011. Its corporate headquarters are situated in Laguna Hills, California.
Market snapshot
- Symbol
- SONX
- Price
- $0.60
- Day change
- 0.00%
- Market cap
- $256.4K
- P/E ratio
- -1.02x
- 52-week range
- 0.02-1.15
- Sector
- Healthcare
- Industry
- Medical - Devices
- Next earnings
- in 2 months
- Analyst price target
- $4.13
Peer companies
Recent insider activity
- McGaugh John P. — A-Award (500000 shares) on 2024-09-17
- Bostjancic John J. — A-Award (600000 shares) on 2024-09-17
- Bergheim Bjarne — A-Award (1600000 shares) on 2024-09-17
- Pudipeddi Vamsi Mohan Raj — A-Award (200000 shares) on 2024-09-17
- BEAVER CAROLYN — A-Award (200000 shares) on 2024-09-17
Open Sonendo, Inc. (SONX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.